Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population
Open Access
- 27 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 40 (6) , 508-512
Abstract
Van't Veer and colleagues developed a 70-gene prognosis profile known as MammaPrint to identify breast cancer patients who were at low risk of developing metastases. We evaluated the prognostic value of the 70-gene MammaPrint profile in Japanese women with node-negative breast cancer. Frozen tumour samples from 102 eligible node-negative breast cancer patients aged 70 or younger were characterized with the MammaPrint array. The patients were treated with breast-conserving therapy or mastectomy with axillary lymph node dissection between December 1998 and August 2001. About 73 percent received adjuvant hormonal therapy and 28 percent received adjuvant chemotherapy. The gene expression profiles obtained by MammaPrint classified the patients as high- or low-genomic risk. The median follow-up was 7.1 years. Among the 102 patients, 20 (20%) were classified as low-genomic risk and 82 (80%) were classified as high-genomic risk. The probability of distant metastasis-free survival at five years was 100% for the low-risk group and 94% for the high-risk group. The 70-gene MammaPrint prognosis profile accurately identified Japanese breast cancer patients at low risk of developing recurrences. In fact, 100% of the individuals in the low-risk category remained metastasis-free for the duration of the observation period.Keywords
This publication has 14 references indexed in Scilit:
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- Cancer Incidence and Incidence Rates in Japan in 2001 based on the Data from 10 Population-based Cancer RegistriesJapanese Journal of Clinical Oncology, 2007
- Converting a breast cancer microarray signature into a high-throughput diagnostic testBMC Genomics, 2006
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Validation and Problems of St-Gallen Recommendations of Adjuvant Therapy for Node-negative Invasive Breast Cancer in Japanese PatientsJapanese Journal of Clinical Oncology, 2001
- Molecular portraits of human breast tumoursNature, 2000